Statistics
Publications
7
Citations
130
H-Index
7
Active since
2017
Tim Preijers is an author at Erasmus MC specializing in hemostasis, medicine, and factor viii replacement.
Publications per year
2017–2023
7
7
Improving the tolerability of osimertinib by identifying its toxic limit
Bram C. Agema, G. Veerman, C. Steendam et al. · Therapeutic Advances in Medical Oncology · 2022 · 41 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII
Tim Preijers, Iris van Moort, Karin Fijnvandraat et al. · Thrombosis and Haemostasis · 2018 · 23 citations · Full text
Tim Preijers, H.C.A.M. Hazendonk, Karin Fijnvandraat et al. · Journal of Thrombosis and Haemostasis · 2017 · 15 citations · Full text
Medicine, Bioinformatics, Hematology +14
Iris van Moort, Tim Preijers, Laura H. Bukkems et al. · The Lancet Haematology · 2021 · 13 citations · Full text
1–5 of 7